April 2026
Advised Asset Allocation on the sale of Lock Finance to AI start-up, Runway Group.
March 2026
Advised the purchaser of a majority stake in a limited partnership which is currently developing a medihotel and associated facilities in Grafton, […]
April 2025 and ongoing
Advised Armourguard Logistics and Evergreen International (US) on the acquisition of ACM New Zealand (approved by the NZ Commerce Commission) and subsequent […]
March 2021
Advised Alpine Bird Manufacturing on the sale of its 50% limited partnership interest in Action Manufacturing LP (Australasia’s largest vehicle specialiser) to […]
January 2021
Advised Clinician Holdings on its latest investment round, raising US$5.4m at a pre-money valuation of more than US$40m.
December 2020
Advised the investors on the latest investment round for Helius Therapeutics – an additional $15m invested in Series D, (increasing total investment […]
October 2020
Advised the lead investor syndicate on the latest investment round for Nyriad Limited which raised in excess of $33m of new equity […]
April 2020 to date
Advising Covid-19 Vaccine Corporation (and its investors) on capital raising and licensing arrangements ($4.3m invested to date).
Selected Topics Relating to Raising Private Capital and Negotiating Investment Terms
ADLSI Commercial Transactions Series Raising Capital from Private Investors or the Crowd SCOPE This paper comprises a selection of articles prepared by […]
March 2019
Advised Clinician Holdings on its investment round to raise approx. US$2.4m from NZ investors and Australian and Singapore VCs.